Ethyl 5-hydroxy-2-methyl-1-benzofuran-3-carboxylate, 98+%, 50mg

Magnesium carbonate hydroxide pentahydrate, 98.00%, 500g

N-Cbz-N'-Methylethylenediamine hydrochloride, 95.0%, 100mg

3-(4-Bromophenyl)-3-methylbutanoic acid, 250mg

4-Amino-1-methylpiperidine>98.0%(GC)(T)25g

H-Lys(Fmoc)-OH, 95%, 1g

1-Bromo-4-chloro-2-fluoro-5-methoxy-benzene, 97.0%, 1g

5-Bromo-4-chloro-2-methylpyridine, 95.0%, 250mg

Rojo o-cresol, 10 g.

2-(3-Oxopyrrolidin-1-yl)acetic acid hydrochloride, 96%, 250mg

4-(3-METHOXY-4-NITROPHENYL)THIOMORPHOLINE 1-OXIDE, 95.0%, 1g

Recipiente de cristalización DURAN® sin pico, 20 ml, 40 mm, 10 Unidad(es)

Methyl (S)-2-(4-(4-chlorophenyl)-2-formyl-3,9-dimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)acetate, 95%, 50mg